Hims & Hers Expands to Canada
This is a Canada news story, published by CNBC, that relates primarily to Ozempic news.
Canada news
For more Canada news, you can click here:
more Canada newsOzempic news
For more Ozempic news, you can click here:
more Ozempic newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsCNBC news
For more news from CNBC, you can click here:
more news from CNBCAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Novo Nordisk. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest semaglutide drugs Ozempic news, Canadian semaglutide market news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
semaglutide drugsCNBC
•Health
Health
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

83% Informative
Hims & Hers Health announced plans to expand to Canada in 2026 .
Hims will offer generic copies of semaglutide drugs Ozempic and Wegovy in Canada .
Novo Nordisk will lose its patent protection on its GLP-1s in Canada after not paying a maintenance fee in 2019 .
VR Score
82
Informative language
83
Neutral language
29
Article tone
semi-formal
Language
English
Language complexity
65
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
3
Affiliate links
no affiliate links